. . . . . . . "[To determine whether PPAR? ligands are equally effective at inhibiting AR activity in androgen-independent prostate cancer, we examined the effect of the PPAR? ligands ciglitazone and rosiglitazone on C4-2 cells, an androgen- independent derivative of the LNCaP cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:33+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .